Atlas Trials

Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

Clinical trial NCT03121677 · TERMINATED

Trial details

NCT number
NCT03121677
Sponsor
Washington University School of Medicine
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Follicular Lymphoma
Start date
2018-10-16
Primary completion
2020-09-24
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.